Cancer cells often acquire mutations in genes that regulate cell cycle checkpoints. Key proteins involved in these checkpoints include p53, ATM, CHK1, and CHK2. Mutations in these proteins can lead to checkpoint failure, allowing cells with damaged DNA to continue dividing. For example, the loss of p53 function is seen in over half of all human cancers and is closely associated with checkpoint dysfunction.
